Literature DB >> 14491415

[Cumulation and elimination of phenobarbital].

H REMMER, M SIEGERT.   

Abstract

Entities:  

Keywords:  PHENOBARBITAL/metabolism

Mesh:

Substances:

Year:  1962        PMID: 14491415

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  9 in total

1.  [ACTIVATION OF MICROSOME ENZYMES BY HEXACHLOROCYCLOHEXANE ISOMERS. ITS EFFECT ON SCILLIROSIDE POISONING IN RATS].

Authors:  W KORANSKY; J PORTIG; H W VOHLAND; I KLEMPAU
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-04-09

2.  [ACCELERATED DRUG DEGRADATION BY ENZYME INDUCTION IN DOGS AFTER TREATMENT WITH PHENOBARBITAL].

Authors:  H REMMER; M SIEGERT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

3.  [INCREASE IN DRUG OXIDIZING ENZYME ACTIVITY WITH TOLBUTAMIDE].

Authors:  H REMMER; M SIEGERT; H J MERKER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-10-02

4.  Oxidation of barbiturates and the glucuronidation of 1-napthol in perfused rat liver and in microsomes.

Authors:  K W Bock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Pharmacokinetics of phenobarbital in childhood.

Authors:  G Heimann; E Gladtke
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

6.  [Dependency of the cortical spindle activity on serum barbiturate level].

Authors:  H H Wieck; A Weis; H Brilmayer
Journal:  Dtsch Z Nervenheilkd       Date:  1966-08-11

7.  Disposition of valproic acid in man.

Authors:  R Gugler; A Schell; M Eichelbaum; W Fröscher; H U Schulz
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

8.  Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse.

Authors:  H Iven; E Feldbusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

9.  Kinetics of phenobarbital in normal subjects and epileptic patients.

Authors:  A J Wilensky; P N Friel; R H Levy; C P Comfort; S P Kaluzny
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.